Aethlon Medical Inc expected to post a loss of 86 cents a share - Earnings Preview

Aethlon Medical

11/08/2025 22:07

Aethlon Medical Inc AEMD.OQ AEMD.O is expected to  show no change in quarterly revenue when it reports  results on August 13 for the period ending June 30 2025

​LSEG's mean analyst estimate for Aethlon Medical Inc is for a loss of 86 cents per share.

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts had risen by about 2.9% in the last three months. ​

Wall Street's median 12-month price target for Aethlon Medical Inc is $3.03, about 59.3% above its last closing price of $1.23

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.98
-1.01
-7.97
Missed
-689.1
Dec. 31 2025
-1.68
-1.71
-1.04
Beat
39.1
Sep. 30 2024
-1.60
-1.56
-1.60
Missed
-2.6​
Jun. 30 2024
-2.45
-2.52
-2.72
Missed
-7.9
​​Mar. 31 2024
-11.28
-9.84
-7.28
Beat
26
Dec. 31 2023
-9.84
-9.84
-10.96
Missed
-11.4​
Sep. 30 2023
-10.40
-11.20
-9.76
Beat
12.9
Jun. 30 2023
-9.60
-10.40
-11.20
Missed
-7.7

This summary was machine generated August 11 at 21:07 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)